20 May 2013
Keywords: bayer, files, 2nd, generation, kogenate, filed, biologics
Article | 25 June 1998
Bayer has filed a Biologics License Amendment in the USA for a newpurified form of its recombinant Factor VIII product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 1998
17 May 2013
© 2013 thepharmaletter.com